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Abstract
Background: Tissue gene expression is generally regulated by multiple transcription factors (TFs). A major first step
toward understanding how tissues achieve their specificity is to identify, at the genome scale, interacting TFs
regulating gene expression in different tissues. Despite previous discoveries, the mechanisms that control tissue
gene expression are not fully understood.
Results: We have integrated a function conservation approach, which is based on evolutionary conservation of
biological function, and genes with highest expression level in human tissues to predict TF pairs controlling tissue
gene expression. To this end, we have identified 2549 TF pairs associated with a certain tissue. To find interacting
TFs controlling tissue gene expression in a broad spatial and temporal manner, we looked for TF pairs common to
the same type of tissues and identified 379 such TF pairs, based on which TF-TF interaction networks were further
built. We also found that tissue-specific TFs may play an important role in recruiting non-tissue-specific TFs to the
TF-TF interaction network, offering the potential for coordinating and controlling tissue gene expression across a
variety of conditions.
Conclusion: The findings from this study indicate that tissue gene expression is regulated by large sets of
interacting TFs either on the same promoter of a gene or through TF-TF interaction networks.
Background
Transcriptional regulation in eukaryotic organisms is a
fundamental process to determine a gene’s spatial and
temporal expression. One of the main events involved in
this process is the binding of TFs to short DNA motifs,
called transcription factor binding sites (TFBSs), on the
promoter regions of genes, activating or repressing the
transcription machinery. In mammalian tissues most
TFs do not act alone, but work through combinatorial
regulation [1,2], in which two or more TFs work syner-
gistically to control individual gene expression. This
combinatorial regulation is able to increase the specifi-
city and flexibility of genes in controlling tissue develop-
ment and differentiation. Therefore, one of the major
first steps toward understanding how tissues achieve
their specificity is to identify interacting TFs regulating
gene expression in different tissues.
Early attempts to identify interacting TFs controlling
tissue gene expression came from the use of experimen-
tal approaches such as gel retardation assay [3], site-
directed mutagenesis [4], chromatin immunoprecipita-
tion [5,6], and genomic microarrays [5,6] in tissues such
as liver [3,5-8], pancreas [6], immune systems [9,10],
muscle [11-13], and neural stem cells [14]. In these stu-
dies, interactions between TFs were discovered on a lim-
ited scale. To overcome this limitation, some researchers
built models to predict tissue-specific cis-regulatory
modules in liver [15,16] and muscle [17] tissues. Taking
advantage of the unprecedented amount of sequence
and gene expression information from the most recent
technical and experimental advances, a few researchers
have developed computational approaches to predict tis-
sue-specific TFs and cis-regulatory modules based on
recognizable sequence features from either highly
expressed genes [18] or genes expressed only in a parti-
cular tissue [19-21] derived from genome-wide gene-
expression profiling. Some of these researchers have
defined tissue-specific enhancers by combining gene-
expression profiling, genome comparison, and TFBS
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relative position and co-occurrence of TFBSs in the pro-
moters of genes expressed only in a particular tissue
[19]. Others have looked for tissue-specific cis-regulatory
modules by enrichment analysis for motifs discovered de
novo in tissue-specific promoters relative to other pro-
moters from the same species [21]. Despite all these
efforts, the mechanism that determines tissue develop-
ment and differentiation is still not fully understood, as
the regulation of tissue gene expression involves com-
plex combinatorial interactions between TFs.
In this study, rather than using sequence features of
promoters from genes that are expressed only in a par-
ticular tissue [19-21], we used our function conserva-
tion approach [22] to predict interacting TFs from the
most highly expressed genes in each of 79 human tis-
sues [23]. Our approach predicts interacting TFs by
integrating the function conservation of interacting
TFs from both their binding sites and target genes
between closely related species, which are based on the
following two assumptions. The first is based on the
strong possibility that functional TFBS pairs have more
distance constraint than random co-occurrence of
TFBSs. The second relies on the biological assumption
t h a tw h i l eaT Fp a i rp l a y st h es a m er o l ei nr e g u l a t i n g
gene expression between closely related species, the
occurrence of its binding sites is expected to be more
highly enriched in promoter sequences of orthologous
g e n e st h a ni np r o m o t e rs e q u e nces of non-orthologous
genes. Other than function conservation, the use of
highly expressed genes in a tissue allows one to avoid
the elimination of common genes contributing to tis-
sue development and differentiation between tissues,
especially for closely related tissues (e.g. skeletal mus-
cle and heart), when compared to the use of tissue-
specific genes [19-21] which are expressed only in a
particular tissue. To our knowledge, this is the first
use of a function conservation approach and highly
expressed genes in tissues for interacting TF predic-
tion. Therefore, the findings provide novel insight into
how tissue gene expression is controlled.
The application of the function conservation approach
to the most highly expressed genes has led to the pre-
diction of hundreds of interacting TFs from each of the
79 human tissues. Based on these predictions, TF pairs
associated with a certain tissue were identified. The
validity of these discovered TF pairs has been evaluated
by both known interacting and liver-specific TFs. We
further extended our study to find interacting TFs con-
trolling gene expression in a broad spatial and temporal
manner by looking for TF pairs common to the same
type of tissues, from which TF-TF interaction networks
were further built. As a first step to elucidating cis-
regulatory modules involved in tissue gene regulation,
we also performed analysis to identify interactions of 3
TFs.
Results
Overall analysis procedures
The overall analysis procedures are shown in Additional
File 1 and Figure 1. We employed our previously devel-
oped function conservation approach [22] to first search
for TF pairs using the top 300 expressed genes (referred
to tissue-expressed genes) [18] in each of the 79 human
tissues from the GNF Atlas2 gene expression database
(gnfAtlas2) [23] and their corresponding mouse ortholo-
gous genes (Additional File 1). We also utilized promo-
ter sequences from 1018 human housekeeping genes
[24] and their mouse orthologous genes to predict inter-
acting TFs playing ubiquitous roles in different tissues
(see Methods).
We next filtered out the TF pairs in a particular tissue
common to those from housekeeping genes (Figure 1a).
The remaining TF pairs (referred to tissue TF pairs) in
each tissue were more tissue-specific. The rationale for
this filtering is that in each tissue some of the interact-
ing TFs play general roles, since all tissues possess com-
mon mechanisms to control the fundamental biological
processes. To find interacting TFs controlling tissue
gene expression in a broad spatial and temporal manner,
we extended the analysis to identify tissue TF pairs
common to the same type of tissues (referred to tissue-
type TF pairs) as well as interactions of 3 TFs. For the
former, we looked for common tissue TF pairs in at
least 50% tissues of the same type (Figure 1a). We also
built TF-TF interaction networks by joining 2 or more
tissue-type TF pairs with one shared TF between TF
pairs in the same tissue. TF-TF interaction networks
with the same topology in at least 2 tissues from the
same tissue type were defined as “tissue-type TF-TF
interaction networks” (Figure 1c). Finally, a two-step
analysis of TFBS conservation and enrichment of over-
lapping TF target orthologous genes was performed to
predict interactions of 3 TFs (Figure 1b).
Identification of tissue TF pairs
Using the function conservation approach [22] and tis-
sue-expressed genes in each of the 79 human tissues, we
were able to identify a few hundred TF pairs for each
tissue, for which BM-CD71+early erythroid has the lar-
gest number of 383 TF pairs, and the ovary tissue has
the smallest number of at 230. We also identified 647
TF pairs from housekeeping genes. Filtering TF pairs of
housekeeping genes from those in each tissue has
greatly reduced the number of TF pairs in each tissue,
ranging from 39% TF pairs for lymph node to 59% TF
pairs for BM-CD105+endothelial, indicating that a large
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different tissues. The resulting tissue TF pairs range
from 111 to 176 for different tissues. We also searched
for TF pairs specific to one tissue (referred to tissue-
unique TF pairs) and obtained from 2 to 20 such TF
pairs for different tissues. The number of tissue TF pairs
and tissue-unique TF pairs for each of the 79 human
tissues are summarized in Table 1. The top 5 tissue TF
pairs that have the most significant correlations between
enriched TFBS pairs and enriched overlapping ortholo-
gous genes are also listed for each tissue.
Overall, we identified 2549 tissue and 803 tissue-unique
TF pairs for the 79 human tissues. These results indicate
that tissue gene expression is regulated by large sets of
interacting TFs. Furthermore, the relative small number of
tissue-unique TF pairs out of all tissue TF pairs suggests
that identical tissue TF pairs in different tissues may play
different functional roles, which prompted us to investi-
gate their biological function. For this purpose, we used
Gene2go http://www.ncbi.nlm.nih.gov/ to annotate human
genes whose promoters contained the target TFBS pairs,
as TFs control cellular biological processes via transcrip-
tional regulation of groups of genes with similar functions.
Significant (q-value < 0.1) biological processes for tissue
T Fp a i r sw e r eo b t a i n e db yc o m p a r i n gt h en u m b e ro fT F
target genes involved in a particular biological process to
the number of genes for the same biological process in the
whole human genome (Fisher’s exact test; p =2 . 4×1 0
-4
to 8 × 10
-28). All tissue and tissue-unique TF pairs as well
as their potential biological functions are listed in Addi-
tional File 2.
Evaluation by known interacting TFs
Although the function conservation approach has been
proven to be a successful means for predicting
interacting TFs [22], we sought to assess the validity of
the identified tissue TF pairs. We first used TRANS-
Compel® 10.4 [25] to determine if known interacting
TFs were statistically enriched in the predicted tissue TF
pairs. The TRANSCompel® database contains 180
experimentally proven composite elements of two or
more binding sites which were previously identified by
individual wet lab studies from others. Of the180 com-
posite elements, 105 were mapped to the 23,005
(214*215/2) possible combinations of 2 TFs from the
214 non-redundant position weight matrices (PWMs).
We first investigated the statistical significance for the
occurrence of known interacting TFs in both predicted
TF pairs (before filtering) and tissue TF pairs in each of
the 79 tissues. Figure 2 shows that known interacting
TFs display enrichment more in the tissue TF pairs then
in predicted TF pairs for both the number of tissues (37
vs. 9) and the degree of enrichment (Binomial test: p =
3.2 × 10
-2 to 6.8 × 10
-6 vs. p =4×1 0
-2 to 3.4 × 10
-4).
We also computed the occurrence of known interacting
TFs in all predicted TFs pairs (before filtering) and all
tissue TF pairs from the 79 tissues. We found that 40
(38.1%) of the 105 known interacting TFs were in both
predicted TF pairs (Binomial test; p =6 . 4×1 0
-9)a n d
tissue TF pairs (Binomial test; p = 5.4 × 10
-11).
To further verify our prediction, we next compared
the tissue TF pairs to known tissue-specific TFs from
liver, for which the cis-regulatory systems for both indi-
vidual TF binding and synergistic actions have been
thoroughly studied [3,4,25,26]. These studies found 40
liver-specific single TFs and 27 liver-specific interacting
TFs. We first computed the tissue TF pairs whose two
TFs were all liver-specific based on the 820 (40*41/2)
possible combinations of 2 TFs from the 40 liver-
Figure 1 Flowchart of analysis procedures. (a) Identification of tissue and tissue-type TF pairs. (b) Prediction of interactions of three TFs. (c)
Reconstruction of tissue-type TF-TF interaction networks. HK: housekeeping genes; hs: human; mm: mouse.
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Page 3 of 15Table 1 Summary of the identified tissue and tissue-unique TF pairs as well as top 5 tissue TF pairs in the 79 human
tissues.
Tissue # tissue TF
pair
# tissue Unique
TF pair
Top 5 tissue TF pairs Literature
support
Fetal liver 150 17 HNF3:HNF4ALPHA**, MYOGNF1:PPARA*, PPARA:PAX2*, HNF1:OCT4*, CMAF:
COUP_DR1*
[4]
Liver 162 18 CEBPGAMMA:HNF4ALPHA**, HNF4ALPHA:HNF4ALPHA**, CEBPGAMMA:
CEBPGAMMA*, AIRE:HNF3*, HNF3B:RUSH1A*
[3,26,41]
Fetal lung 149 9 CEBP:HNF4ALPHA**, CEBP:CEBPA**, VDR:OCT, CEBPGAMMA:PLZF, FOXJ2:
GATA4
[3,41]
Lung 111 8 EBOX:HNF4ALPHA**, CEBP:ETS**, SP3:WT1*, CACD:CETS1P54, EBOX:SPZ1 [42,43]
Kidney 173 15 HNF3:HNF4ALPHA**, PPARA:SP3, AP2:HAND1E47, AP2:ER, TEL2:SREBP [4]
Pancreas 146 14 HNF3:HNF4ALPHA**, AP2:TBP*, DEC:MYOGNF1, GATA4:PAX4*, HNF4ALPHA:
YY1
[4]
Pancreatic islets 125 9 SP1:SREBP1**, E2A:ZF5_B*, CP2:CP2, CHOP:OCT1, OCT:RUSH1A
Cardiac myocytes 139 12 HNF3:HNF3B**, CEBP:PAX4, POU3F2:PAX4, NFAT:SP3, TST1:SREBP1 [4]
Heart 130 10 MYOGNF1:SP3*, CP2:ZIC3, AP2:TAXCREB, TAL1BETAE47:MAF, FAC1:OCT1
Skeletal muscle 121 15 OCT1:SP1**, MYOGNF1:DR4*, NKX25:TBP*, TEL2:ZIC3, AP2ALPHA:CP2 [44]
Smooth muscle 137 10 HMGIY:OCT**, EGR1:MYOGNF1*, TST1:PAX2, AP2:TST1, POU3F2:CEBP
Tongue 152 17 CEBP:CEBPA**, HNF4ALPHA:SREBP1, MYOGNF1:VDR*, HIC1:MYOGNF1*, CP2:
ZIC3
[41]
Uterus 144 12 AP1:HMGIY**, HAND1E47:ZIC3*, PLZF:YY1*, AIRE:PLZF, SP3:WT [45]
Uterus corpus 158 17 HMGIY:OCT**, HNF3:MYOGNF1*, CP2:E2A*, NF1:SP1*, OCT4:TGIF [46]
Ciliary ganglion 149 15 AP1:STAT**, CACD:CETS1P54, MYOGNF1:NFY, CETS1P54:VDR, AP2:OCT4* [47,48]
Dorsal root ganglion 155 15 CEBP:CEBPGAMMA**, FOXJ2:DR3, AREB6:FOXJ2, CEBP:TST1*, AP2ALPHA:
GEN_INI3_B*
[41]
Spinal cord 144 6 ETS:HMGIY**, HIC1:PPARA*, NKX25:PLZF, PPARA:TBP*, CART1:MYOGNF1 [10]
Superior cervical
ganglion
157 15 CEBPGAMMA:HNF4ALPHA**, AP1:PLZF*, ETF:HOXA4*, FAC1:GATA4, DR3:TBP* [3]
Trigeminal ganglion 166 18 ETS:VDR**, TEL2:SPZ1, MINI19_B:PLZF, AP2ALPHA:PAX4*, CP2:TST1* [49]
Amygdala 148 7 OCT1:OCT1**, PAX:STAT*, EGR1:PAX2, AP2:CETS1P54*, MRF2:HMGIY [50,51]
Caudate nucleus 161 6 CEBPGAMMA:CEBPGAMMA**, ETS:VDR**, AP2ALPHA:KROX*, GATA4:XVENT1,
CEBPGAMMA:HMGIY
[41]
Cerebellum 149 11 CEBPGAMMA:HMGIY, VDR:TAXCREB*, OSF2:PAX2, DR4:SPZ1*, FAC1:OCT4*
Cerebellum
peduncles
123 6 CEBPGAMMA:CEBPGAMMA**, ETS:MYB**, ETS:VDR*, CART1:FAC1, DR4:SPZ1* [41]
Cingulate cortex 131 3 EBOX:ETS**, ETS:HMGIY**, NKX25:TBP*, MRF2:OCT4* AP2:XVENT1* [10,52,53]
Fetal brain 121 12 ETS:HMGIY**, MINI19_B:SRY*, AHRARNT:VDR*, CACD:TAXCREB*, CDXA:HMGIY [53]
Globus pallidus 145 8 ETS:VDR**, NKX25:TBP*, NKX25:PAX5, AHRHIF:KROX*, AP2:SREBP* [49]
Hypotalamus 134 5 ETS:HMGIY**, CEBPGAMMA:CEBPGAMMA**, AP2:PPARA*, AP2:PPARA*, PAX:
SREBP1*
[41,53]
Medulla oblongata 124 3 VDR:TAXCREB*, CEBPGAMMA:HMGIY, AP2:ETF*, MAF:PAX4*, MYOGNF1:ZIC3
Occipital lobe 132 6 AP2:XVENT1*, NKX25:TBP*, AP2:PPARA*, AP2ALPHA:KROX*, PAX:STAT*
Olfactory bulb 155 7 CEBPA:GRE_C, AP2:TST1*, OCT:TST1*, CEBPGAMMA:HMGIY, AP2:PAX4*
Parietal lobe 125 2 EBOX:ETS**, TTF1:VDR, AP2:XVENT1*, NKX25:TBP*, CP2:HIC1 [52]
Pons 160 3 ETS:HMGIY**, OCT1:OCT1**, ETS:VDR**, GATA:GATA4*, AP2:SREBP* [50,53]
Prefrontal cortex 131 6 PAX:STAT*, AP2:XVENT1*, CMAF:SP3, TAL1BETAE47:PAX2, AHRHIF:KROX*
Subthalamic nucleus 128 5 OCT:PAX5*, NKX25:TBP*, AP2ALPHA:DR4*, AHRHIF:KROX*, CP2:ZIC3
Temporal lobe 138 8 AP2:ETF*, PAX3:SP1*, POU3F2:MYOGNF1*, NKX25:TBP*, CETS1P54:HMGIY
Thalamus 137 11 PAX:STAT*, CEBPGAMMA:GEN_INI3_B, XVENT1:YY1, MAZ:VMYB, AP2ALPHA:
PLZF*
Whole brain 130 8 CEBPGAMMA:CEBPGAMMA**, GATA:OCT4*, AP2:PPARA*, AP2:PPARA*,
POU3F2:NFAT*
[41]
BM CD105+
endothelial
143 10 OCT:STAT**, CEBPGAMMA:PLZF*, ER:TBP*, GRE_C:PPARA, M YOGNF1:SP1* [54]
BM CD34+ 158 7 ETS:HMGIY**, CEBPGAMMA:PLZF*, ETF:TST1*, ETS:RUSH1A*, TAL1BETAE47:
SP3*
[53]
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(Continued)
BM CD71+
earlyerythroid
145 8 PAX4:YY1*, GEN_INI3_B:GEN_INI3_B, KROX:NF1*, NF1:SP1*, CP2:CP2
BM_CD33+ myeloid 164 16 CEBP:CEBPA**, ETS:VDR**, AP2ALPHA:EGR1* P300:SREBP1, CETS1P54:VDR* [41,49]
Bone marrow 154 16 CEBP:CEBPA**, DR4:SPZ1*, AP2:OCT4, VDR:SREBP*, DR3:WT1* [41]
Lymph node 157 7 MINI19_B:LRF, OCT4:PAX4, CP2:ZIC3, AP2ALPHA:TTF1, TAL1BETAE47:PPARA*
PB BDCA4+ dentritic
cells
159 9 CEBPA:CEBPGAMMA**, KROX:PPARA*, CEBP:TST1*, TST1:PAX2*, DR3:P300* [41]
PB CD14+ monocytes 146 9 CEBP:CEBPA**, TFE:TST1*, NF1:PAX8, NF1:ZIC3, MYOGNF1:SP1* [41]
PB CD19+ Bcells 143 5 HMGIY:OCT**, DBP:TBP*, ETS:HOXA4*, CP2:CP2, RUSH1A:RUSH1A [46]
PB CD4+ Tcells 161 10 ETS:SP1**, CEBPGAMMA:CEBPGAMMA**, CP2:SZF11, FAC1:VMYB, AREB6:
GATA4
[41,55]
PB CD56+ NKCells 125 10 ETS:GRE_C, CEBPA:CEBPGAMMA**, OCT1:SPZ1* CEBP:TST1*, AP2:GRE_C [41]
PB CD8+ Tcells 155 8 ETS:SP1**, AREB6:GATA4, AP2ALPHA:MAZ, TTF1:OCT1_07*, KROX:XVENT1* [55]
Thymus 164 11 EBOX:HNF4ALPHA**, CEBPA:CEBPGAMMA**, AP1:STAT**, ETS:RUSH1A*, TBP:
YY1*
[41,42]
Tonsil 158 10 CEBP:CEBPGAMMA**, NF1:P300, CACD:TAL1BETAE47*, PPARA:SP1*, OSF2:
CDXA
[41]
Whole blood 132 8 CEBPGAMMA:CEBPGAMMA**, PPARA:SP3*, ETS:VMYB*, SP3:YY1*, NFAT:PLZF* [41]
Ovary 127 9 CEBPA:SREBP1, GATA_C:MAF, LRF:NKX25, NF1:ZIC3, CHOP:PAX4
Testis 149 9 CEBPGAMMA:CEBPGAMMA**, DR4:SPZ1*, POU3F2:PAX4, MYOGNF1:ZIC3,
MYOGNF1:SP1
[41]
Testis germ cell 136 8 HAND1E47:SPZ1*, SP3:WT1, DBP:TBP, TEL2:LRF, POU3F2:COUP_DR1
Testis interstitial 115 5 CEBP:CEBPGAMMA**, MYOGNF1:SPZ1*, DR4:SPZ1*, CEBPGAMMA:HMGIY,
EBOX:SREBP1
[41]
Testis leydig cell 135 6 MYOGNF1:SPZ1*, FAC1:FOXJ2, TTF1:PPARA, GATA4:RUSH1A, HOXA4:OCT
Testis seminiferous
tubule
157 9 STAT:STAT**, DR4:SPZ1*, FAC1:FOXJ2, AHRHIF:AP2ALPHA, CMAF:PPARA [56]
Adrenal cortex 147 17 CEBP:NFAT**, PPARA:SP1, HMGIY:ZF5_B, AP2:TST1, AP2ALPHA:TST1 [57]
Adrenal gland 157 8 PAX3:WT1, PPARA:SP3, TAL1BETAE47:CRX, DR3:SP3, CETS1P54:OCT
Fetal thyroid 127 9 CEBPA:CEBPGAMMA**, TST1:PAX2, CART1:PPARA, DR3:SP3, AP2:PPARA [41]
Pituitary gland 133 19 EBOX:P300, OSF2:YY1, AP2:PPARA, SP3:WT1, EGR1:ZF5_B*
Prostate 176 12 CEBPA:ETS**, EBOX:ETS**, ETS:VDR**, AP1:DR3, KROX:NF1 [43,58]
Salivary gland 132 11 CEBPGAMMA:CEBPGAMMA**, AP2:POU3F2, TTF1:TTF1, CEBPA:CEBPGAMMA,
EGR1:P300
[41]
Thyroid 122 11 CEBPA:CEBPGAMMA**, PPARA:SREBP1, GRE_C:SREBP1, MINI19_B:DR3, CMAF:
YY1
[41]
721 B lymphoblasts 168 11 CART1:YY1, CP2:ZIC3, HMGIY:PAX4, DBP:TTF1, TEL2:P300
Colorectal
adenocarcinoma
143 11 FOXJ2:EFC, CART1:HOXA4, MINI19_B:DR4, SP3:WT1, OCT4:PAX2
Leukemia chronic
myelegenous
151 9 TCF11:NFAT, NCX:PAX2, ETF:SRY, NF1:ZIC3, AP2ALPHA:AREB6
Leukemia
lymphoblastic
156 17 AP2ALPHA:PAX4, CEBPA:PLZF, AP2ALPHA:TST1, AP2:PPARA, HMGIY:ZF5_B
Leukemia
promyelocytic
154 6 CEBPGAMMA:CEBPGAMMA**, DR4:SPZ1, CEBPA:FAC1, P300:ZIC3, CP2:ZIC3 [41]
Lymphoma burkitts
daudi
147 12 ETS:MYB**, CETS1P54:WT1, CP2:P300, CP2:EBOX, MINI19_B:WT1 [59]
Lymphoma burkitts
Raji
131 5 NFAT:OCT1**, PPARA:SP3, E2A:MYOGNF1, CETS1P54:MYB, AREB6:CDPCR3 [60,61]
Adipocyte 142 14 PPARA:SP1, EGR1:ZF5_B, SP3:SP3, AP2:SRY, PPARA:WT1
Appendix 136 8 CEBP:NFAT**, ETS:VDR**, TAL1BETAE47:TEL2, SP3:WT1, DR4:SP3 [57]
Atrioventricular node 140 13 ETS:GRE_C, AREB6:PPARA, ETF:HOXA4, GEN_INI3_B:GEN_INI3_B, AP2:OCT4
Bronchial epithelial
cells
152 14 TTF1:SP1, POU3F2:GATA4, AP2ALPHA:TTF1, CACD:MAZ, CEBPA:GATA4
Placenta 132 5 CEBPA:CEBPGAMMA**, SP3:WT1*, DEC:PAX5, NKX25:STAT1, PPARA:SP1 [41]
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tissue, we were able to obtain 30 (Binomial test; p =2 . 3
×1 0
-14) where both TFs were liver-specific. For the 27
liver-specific known interacting TFs, we found 8 (30%)
in both the predicted TF pairs (Binomial test; p =3 . 6×
10
-9) and tissue TF pairs (Binomial test; p =2 . 9×1 0
-11)
from liver tissue. These include HNF4ALPHA:HNF4AL-
PHA, NF1:COUP_DR1, CEBPGAMMA:HNF4ALPHA,
CEBPA:HNF3B, HNF3:HNF4ALPHA, HNF3:PPARA,
CEPBA:GATA4, and HNF1:OCT1. All of them are key
elements in liver specific transcriptional regulation. GO
enrichment analyses indicated that genes whose promo-
ters contained the predicted liver-specific TFBS pairs
were mainly involved in liver specific functions [27,28],
including oxidation reduction, acute-phase response,
gluconegnesis, and lipoprotein & lipid metabolic pro-
cesses (Additional File 2). Further analysis of the binding
sites on the promoter sequence of individual genes indi-
cated that we were able to reliably identify interacting
TFs similar to those previously reported. One of the
examples was the APOA1 gene, which was well-charac-
terized to be synergistically bound by HNF3 and HNF4
[8]. Our prediction was able to successfully identify the
HNF3:HNF4 binding sites on its promoter. A closer
examination shows that our predicted HNF3 and HNF4
binding sites for the APOA1 gene are exactly those
experimentally proven, liver tissue-specific HNF3 and
HNF4 binding site combinations [8], which are highly
conserved between human and mouse in regards to
both nucleotide sequence and spacing between each
binding site (Figure 3).
It is important to note that the 79 human tissues
represent only part of the temporal and spatial condi-
tions from which the 105 known interacting TFs were
discovered, and therefore it is unlikely to have all
known interacting TFs in our predicted list. Neverthe-
less, our results indicate that the use of function conser-
vation approach and tissue-expressed genes was able to
reliably identify to a great extent known interacting TFs,
thus presenting very strong evidence for the validity of
the identified tissue TF pairs. These results also indicate
that filtering the TF pairs of housekeeping genes from
those in each tissue is an important step to eliminate
TFs playing a ubiquitous role, thereby the resulting TF
pairs are more tissue-specific.
Identification of tissue-type TF pairs
One of the goals of this study is to find interacting TFs
controlling gene expression in a broad spatial and tem-
poral manner such as interacting TFs common to the
same type of tissues. This canb ea c h i e v e db ys e a r c h i n g
tissue TF pairs common across all tissues of the same
type such as the 7 muscle tissues. However, the use of all
tissues may reduce the power for tissue-type TF pair
identification, since the contents of tissue TF pairs and
even the function of a common tissue TF pair may be dif-
ferent between tissues of the same type. Therefore, we
sought to first classify tissues into smaller but more clo-
sely related groups based on tissue TF pairs, from which
representative tissues for the same tissue type could be
obtained. Accordingly, we used hierarchical clustering to
group tissues, as no ap r i o r iknowledge was available for
t h en u m b e ro fg r o u p sf o re a c ht i s s u et y p e .T h er e s u l t s
are shown in Figure 4, where tissues of the same type are
generally grouped together such as testis, liver, pancreas,
and brain. There are, however, exceptions for other tissue
types which are grouped into either distinct groups or
into groups with other types of tissues such as muscle
and immune systems. While the muscle tissues are classi-
fied into two distinct groups, of which one contains ske-
letal muscle, heart, and tongue and the other contains
smooth muscle and cardiac myocytes, tissues for immune
systems are classified into a few groups, one of which dis-
plays tighten link with a few cancer tissues.
We extended our analysis to investigate conservation
for tissue TF pairs between tissues of the two muscle
groups. We computed overlap for both tissue TF pairs
and their biological functions between tissues using
hypergeometric distribution. We found little or no over-
lap for both tissue TF pairs and their functions among
tissues between these two groups, which was especially
true for the function of tissue TF pairs (data not
shown). On the other hand, both tissue TF pairs and
their functions showed significant overlap between tis-
sues within the same group (Figure 5). These results not
only demonstrate the validity of our tissue classification
but also indicated that tissues from the same type (here
Table 1: Summary of the identified tissue and tissue-unique TF p a i r sa sw e l la st o p5t i s s u eT Fp a i r si nt h e7 9h u m a nt i s s u e s .
(Continued)
Skin 156 20 CEBPA:CEBPGAMMA**, HNF4ALPHA:PPARA, HMGIY:OCT4, CEBPGAMMA:PLZF,
AP2ALPHA:CP2
[41]
Trachea 146 12 CEBPA:CEBPGAMMA**, CEBP:PAX4, CETS1P54:PPARA, AP2:XVENT1,
AP2ALPHA:TST1
[41]
Top 5 tissue TF pairs are those with the most significant correlation between enriched TFBS pairs and enriched overlapping orthologous genes;
**experimentally proven interacting TFs with literature support; * at least one TF is tissue-specific based on tissue-specific single TFs from TRANSFAC11.4
database [37]
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contents of tissue TF pairs and TF functional roles.
Based on the clustering results, we selected 11 tissue-
type groups, each having 2 to 16 tissues, for tissue-type
TF pair discovery. A cutoff threshold of tissue TF pairs
common in at least 50% tissues from the same group
was set up for searching tissue-type TF pairs. In addi-
tion to the TF level, we also searched for tissue-type TF
pairs based on their function using the same criteria of
>5 0 %t i s s u e si nt h es a m eg r o u p .T ot h i se n d ,w ew e r e
able to identify tissue-type pairs for all tissue groups as
listed in Table 2. Whereas the number of tissue-type TF
pairs ranges from 17 for immune/cancer group to 74 for
testis, those at the functional level have relatively smaller
numbers, ranging from 3 for thyroid to 40 for testis. All
(379) tissue-type TF pairs as well as their corresponding
functions for the 11 tissue-type groups are listed in
Additional File 3.
Reconstruction of tissue-type TF-TF interaction networks
In an effort to reveal TF relationships in controlling tis-
sue gene expression, we performed analysis to recon-
struct TF-TF interaction networks. Using tissue-type TF
pairs, we first looked for those with one shared TF
between each other in the same tissue, from which TF-
TF interaction networks were built by joining 2 or more
TF pairs (Figure 1c). TF-TF interaction networks with
t h es a m et o p o l o g yi na tl e a s t2t i s s u e sf r o mt h es a m e
tissue-type group were then selected as tissue-type TF-
TF interaction networks, which are multi-input network
motifs consisting of at least 3 TFs that bind to a set of
gene promoters. A total of 84 tissue-type TF-TF interac-
tion networks were identified for the 11 tissue-type
groups, ranging from 1 for immune/cancer to 22 for tes-
tis (Additional File 4). Sixty two of these tissue-type TF-
TF interaction networks have a linear relationship
between TFs with 1 to 4 internal TFs (i.e. TF connecting
to 2 other TFs), indicating that the majority of the TF-
TF regulatory networks have simple TF relationships for
controlling tissue gene expression. Figure 6a shows a
multi-input network motif from liver tissues, in which
FOXJ2, HNF1, and TTF1 regulate 6 genes in a combina-
torial manner by either 2 or 3 TFs. The remaining 22
tissue-type TF-TF interaction networks display more
complex interacting structures with some of the internal
TFs connecting to 3 or more TFs.
Unlike the tissue TF pairs, we did not find any common
tissue-type TF-TF interaction networks between differ-
ent tissue types. In light of this, we performed a search
to see if any single TFs played central roles in control-
ling tissue gene expression across different tissues, and
looked for internal TFs in multiple tissue-type TF-TF
interaction networks. To this end, we found that AP2,
PPARA, PAX4, FAC1, ZIC3, and SPZ1 served as inter-
nal TFs in 8, 8, 8, 6, 5, and 4 tissue-type TF-TF interac-
tion networks, respectively, suggesting their role as
central hubs in tissue-type TF-TF interaction networks.
Whereas FAC1 acts as the internal TF in 6 tissue-type
TF-TF interaction networks from immune systems and
cancer, SPZ1 mainly serves as the internal TF in tissue-
type TF-TF interaction networks from testis, and the
rest in 5 to 6 tissue-type TF-TF interaction networks
from different tissue types. These results indicate that
Figure 2 Statistical significance for the occurrence of known
interacting TFs. Validation results (-log10(p-values)) for predicted TF
pairs (orange) and tissue TF pairs (green) in the 79 human tissues.
Dash line indicates significant p-value cutoff which is < 0.05 above
the dash line. Known interacting TFs display enrichment more in
the tissue TF pairs than in predicted TF pairs for both the number
of tissues (37 vs. 9) and the degree of enrichment (Binomial test: p
= 3.2 × 10
-2 to 6.8 × 10
-6 vs. p =4×1 0
-2 to 3.4 × 10
-4).
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Page 7 of 15FAC1, when serving as the internal TF, is restricted to
the two related tissue types, and that SPZ1, a bHLH-Zip
protein, has an important role in testis [29,30]. The rest
have more diversified roles for coordinating network
TFs in controlling tissue gene expression.
It is interesting to note that no single TFs serve as the
central hub for tissue-type TF-TF interaction networks
from liver tissue. However, we observed that 6 of 7
tissue-type TF-TF interaction networks had at least one
known liver-specific TF serving as the internal TF as
shown in Figure 6b. To investigate if this distribution
pattern of liver-specific TFs in the TF-TF interaction
networks had any biological meaning, we randomly
sampled TFs from the 214 PWMs to build TF-TF net-
works, each having the same size and order as the real
TF-TF interaction networks. The simulated TF-TF
Figure 3 Conservation of identified HNF3 and HNF4ALPHA binding sites in human and mouse APOA1 genes. Both schematic and
sequence alignments for the predicted HNF3 and HNF4ALPHA binding sites between human and mouse promoter sequences are depicted. In
the sequence alignment the core motifs are shown in upper case letters and the distances between adjacent binding sites are shown in
brackets. Also shown are the locations of each binding site in relation to the transcriptional starting site.
Figure 4 Hierarchical clustering over tissue TF pairs from the 79 human tissues. The distance matrix was built using the “binary” method,
and hierarchical clustering was performed using the “complete” agglomeration method. Arrows and numbers indicate the selected tissue
groups for further analysis.
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interaction networks to estimate the statistical signifi-
cance for the distribution of liver-specific TFs. The
results indicate that known liver-specific TFs were sig-
nificantly enriched as internal TFs for these 7 tissue-
type TF-TF interaction networks (bootstrap analysis; p <
10
-20). By contrast, the total number of liver-specific TFs
in these 7 tissue-type TF-TF interaction networks was
not enriched (bootstrap analysis; p = 0.11). These results
suggest that liver-specific TFs, other than initiating
liver-specific transcriptional event, may play an impor-
tant role in recruiting non-liver-specific TFs to the tis-
sue-type TF-TF interaction network, thus offering the
potential for coordinating and controlling gene expres-
sion across a variety of conditions.
Prediction of multiple interacting TFs
As a first step to elucidate cis-regulatory modules
involved in tissue gene regulation, we extended our ana-
lysis to the interactions of 3 TFs (named as multiple
interacting TFs). Using tissue TF pairs from each of the
79 tissues, we performed a two-step analysis of TFBS
conservation and enrichment of overlapping orthologous
genes between human and mouse (see Methods).
Although it is likely that multiple interacting TFs may
be under estimation by the use of tissue TF pairs instead
of all predicted TF pairs, the predicted multiple interact-
ing TFs are tissue-specific. Therefore, these predictions
most likely represent cis-regulatory modules involved in
tissue gene regulation. To this end, we identified 1735
unique interactions of 3 TFs for the 79 human tissues,
ranging from 9 multiple interacting TFs for testis inter-
stitial to 72 multiple interacting TFs for caudate nucleus
(Additional File 5).
The validity of these predicted multiple interacting
TFs was assessed by using liver-specific single TFs from
TRANSCFAC11.4 [25], as few known cis-regulatory
modules were available. We performed analysis to see if
known liver-specific TFs were statistically enriched in 30
predicted multiple interacting TFs from liver tissue. We
found 4 of them (bootstrap analysis; p <1 0
-3)w h o s e3
TFs were all liver-specific, 18 (bootstrap analysis; p <
10
-8) with at least 2 liver-specific TFs, and 28 (bootstrap
analysis; p <1 0
-5) with at least 1 liver-specific TF. These
results provide evidence for the enrichment of liver-spe-
cific TFs in the predicted multiple interacting TFs,
which in turn demonstrated the validity of the
prediction.
We next searched for all predicted multiple interacting
TFs and their potential functions that are common
between tissues. The results indicated that, although
common multiple interacting TFs existed between most
tissues, the highest overlap was within brain tissues and
between brain and gland tissues. By contrast, there was
little overlap for the functions of multiple interacting
TFs, except within brain and cancer and between these
2 tissue types (Additional File 6). The latter is especially
interesting to us, as cancer cells have a global effect on
immune systems, which in turn control and shape
developing cancer [31]. Six multiple interacting TFs
were found to have common functions between immune
systems and cancer tissues, including CEBPGAMMA:
NKX25:PLZF, CEBPGAMMA:PAX4:PLZF, CP2:NFY:
PAX4, FOXJ2:PAX4:POU3F2, CEBPGAMMA:PAX4:
PLZF, and FOXJ2:HNF3:PAX4. These results revealed
not only the common mechanisms for transcriptional
regulation but also the common functional role of
Figure 5 Overlapping tissue TF pairs and their functions between muscle tissues. (a) Venn diagram displaying the significant overlap for
both tissue TF pairs and their functions in the group of skeletal muscle. (b) Significant overlap for both tissue TF pairs and their functions in the
group of smooth muscle. Each circle indicates the number of tissue TF pairs. The number of overlapping tissue TF pairs and TF functions
between two tissues is indicated in bold (# function/# TF). Also shown are their corresponding p-values from hypergeometric tests.
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systems, including cell cycle, cell division, DNA replica-
tion, mitosis, phosphoinositide-mediated signaling, and
immune response. These findings therefore provide new
insight into the molecular interplay between cancer and
immune systems.
Discussion
Tissue gene expression is generally regulated by multiple
transcription factors. A major first step toward under-
standing how tissues achieve their specificity is to iden-
tify interacting TFs regulating gene expression in
different tissues. Previous computational approaches to
predict interacting TFs were mainly based on recogniz-
able sequence features of tissue-specific [19-21] genes
derived from genome-wide gene-expression profiling.
Despite these studies, the mechanisms controlling tissue
gene expression are still not fully understood.
In this study, we utilized our previously developed
function conservation approach, which, based on this
and a prior study [22], was shown to successfully predict
interacting TFs from tissue-expressed genes. Based on
the predictions, tissue TF pairs were identified. The
advantage of our approach lies in the fact that it does
not depend solely on sequence features of genes but
rather function conservation of interacting TFs from
both their binding sites and putative target genes
between closely related species. Other than function
conservation, the use of tissue-expressed genes would
allow one to avoid the elimination of common genes
contributing to tissue development and differentiation
between tissues, especially for these closely related tis-
sues (e.g. skeletal muscle and heart) when compared to
the use of tissue-specific genes [19-21] which are
expressed in a particular tissue. Therefore, the utiliza-
tion of our function conservation approach and tissue-
expressed genes provides an alternative way for tissue
interacting TF discovery.
One of the findings of our study indicates that tissue
gene expression is controlled by large sets of tissue TF
pairs, which is in agreement with previously reported
findings from an approach using sequence features of
tissue-specific genes by Yu et al.[ 1 9 ] .W ew e r ec u r i o u s
to know the differences of interacting TFs identified by
the two different approaches, and selected the liver tis-
sue for comparison. For the 8 known liver-specific inter-
acting TFs that were successfully predicted by our
approach in the 162 liver tissue TF pairs, we found that
HNF3:HNF4ALPHA was in the liver-specific TF pairs
predicted by Yu et al. However, we did not find the
other 7 known liver-specific interacting TFs predicted in
our 162 tissue TF pairs from Yu et al. On the other
hand, 6 of the 27 known liver-specific interacting TFs
were correctly predicted by Yu et al but were not in our
Table 2 Number of tissue-type TF pairs in the selected 11
tissue groups.
Tissue type #
Tissues
Cluster
ID
#T F
pairs
# TF pairs with
annotated function
Adrenal
gland*
2C 6 3 1 1 6
Brain 16 C4 45 26
Cancer 4 C3 32 25
Immune/
cancer
3/4 C2 17 14
Immune 4 C10 33 15
Liver 2 C8 30 22
Pancreas 2 C7 23 6
Smooth
muscle*
2 C11 29 14
Skeletal
muscle*
3C 1 3 9 2 6
Testis 5 C5 74 40
Thyroid 2 C9 27 3
* One tissue from the same group is used as the tissue type name.
Cluster ID: clustering ID for the 11 selected tissue groups in Figure 4.
Figure 6 Tissue-type TF-TF interaction networks for liver
tissues. (a) Multi-input network motif for TFs of FOXJ2, HNF1, and
TTF1 and their target genes which are regulated by either two or
three TFs. (b) Topology of seven tissue-type TF-TF interaction
networks for liver tissues. Each node represents a TF and each edge
(link) represents a significant synergy between two TFs from tissue
TF pairs. Previously known liver-specific TFs are labeled with an
asterisk.
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shows that liver-tissue TF pairs from our prediction are
enriched with CEBP, HNF3, and HNF4, and that liver-
specific TF pairs from Yu et al are enriched with HNF1
and HNF4. All these TFs are known liver-specific TFs
such as HNF3 [32], which initiates the liver transcrip-
tional event, and HNF1 [33], which interacts with other
important TFs to establish transcriptional hierarchy in
liver tissues. These results demonstrate that different
methods were able to identify interacting TFs from dif-
ferent angles. Therefore, the findings from our study
provide new insight into the mechanism controlling tis-
sue gene expression.
Filtering TF pairs of housekeeping genes from those of
tissue-expressed genes is an important step to eliminate
TF pairs which play general but not tissue-specific roles
in individual tissues. The filtering process reduced the
number of predicted TF pairs from 3024 to 2549
(15.7%) for all 79 tissues. This reduction for TF pairs
was, however, significantly larger when individual tissues
were concerned (39% to 59%), indicating that a large
number of overlapping TF pairs had ubiquitous roles
among different tissues. The remaining interacting TFs
in each tissue were more tissue-specific, which was best
evidenced by the result that the predicted TF pairs from
liver tissue contained the same number of known liver-
specific interacting TFs before and after the filtering.
The relative small number of tissue-unique TF pairs out
of all tissue TF pairs and the findings from conservation
analysis for the functions of tissue TF pairs between tis-
sues of two muscle groups from this study also indicate
that tissue TF pair with identical 2-TF combination
might play different functional roles in different tissues.
Our findings show that tissue gene expression is con-
trolled by a variety of interacting TFs either on the pro-
moter of a gene or through TF-TF interaction networks.
These identified TF interactions may constitute a large
part of interacting TFs in each tissue but is not a com-
plete list. To fully understand the mechanisms control-
ling tissue gene expression requires additional study,
which has been best evidenced from the comparison of
interacting TFs in liver tissue between Yu et al. [19] and
ours. Other than the prediction methods, the target
gene selection can contribute greatly to tissue TF identi-
fication. Our prediction picked up 8 of the 27 known
liver-specific interacting TFs in liver tissues. A couple
factors might be responsible for not identifying the
other known liver-specific interacting TFs. First, these
known liver-specific TF interactions were discovered
from broad spatial and temporal conditions. The
selected liver genes in this study however represented
only one of many conditions under which liver-specific
TFs play their roles. This was exemplified by known
liver-specific interacting TFs in tissue TF pairs from
liver and fetal liver tissues from our prediction. Whereas
tissue TF pairs from liver tissue contained 8 known live-
specific interacting TFs, fetal liver contained 3 known
live-specific interacting TFs with 2 common to those in
liver, demonstrating the impact of temporal conditions
on tissue TF discoveries. Second, it is unlikely for the
top 300 tissue-expressed genes from a single condition
to all have information for tissue interacting TF predic-
tion. The choice of the top 300 tissue-expressed genes
was based on the report of Pennacchio et al.[ 1 8 ]w h o
have successfully used them to predict tissue-specific
enhancers. Increasing the size of genes however would
increase the chance of bringing noise to the prediction.
Therefore, other than different computational
approaches, selecting a proper list of tissue-expressed
genes would have a great impact on the prediction of
tissue TF pairs.
One of the goals of this study was to find interacting
TFs controlling tissue gene expression in a broad spatial
and temporal manner. We performed analysis to identify
tissue-type TF pairs for 11 selected tissue-type groups.
While, as described above, each specific tissue may
reflect only a small portion of all spatial and temporal
conditions where tissue TF pairs play their regulation
roles, tissue-type TF interactions provide a general view
of their roles in multiple conditions. The analysis pro-
cess has also led to other findings that the same type of
tissues may have significant differences in both the con-
tents of tissue TF pairs and the TF functional roles,
which has been demonstrated by the conservation analy-
sis of tissue TF pairs and their functions from muscle
tissues. Tissue-type TF-TF interaction networks have
provided not only lines of information on how tissue
transcriptional programs are constructed but also new
findings of potential roles for tissue-specific TFs in TF-
TF interaction networks from liver tissue.
Conclusions
In this study, we successfully employed our previously
developed function conservation approach [22], to pre-
dict functional TF pairs from tissue-expressed genes in
79 human tissues. Based on the predictions, tissue TF
pairs were identified. Our analyses led to the discovery
of 2549 unique tissue TF pairs for the 79 human tissues.
The validity of the discovered tissue TF pairs has been
demonstrated by both known interacting and liver-spe-
cific TFs. We also extended our study to find interacting
TFs controlling gene expression in a broad temporal
and spatial manner and identified 379 tissue-type TF
pairs from 11 tissue-type groups, from which tissue-type
TF-TF interaction networks have been built. The results
also indicated that tissue-specific TFs may play an
important role in recruiting non-tissue-specific TFs to
the TF-TF interaction network, offering the potential for
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across a variety of conditions. In summary, our findings
have shown that tissue gene expression is regulated by
large sets of interacting TFs either on the same promo-
ter of a gene or through TF-TF interaction networks.
Methods
Promoter sequences for housekeeping and tissue-
expressed genes
The GNF Atlas2 gene expression database (gnfAtlas2)
[34], which contains gene expression data from 79
human tissues, was used for the selection of genes.
Based on the report of Pennacchio et al [18] we selected
in each tissue the top 300 expressed genes (referred to
tissue-expressed genes), which have been used and pro-
ven to successfully predict tissue-specific enhancers.
Housekeeping genes are the 1018 genes defined by
Farre et al [24]. Redundant genes in each group were
first removed. Although regulatory elements can exist
anywhere in the genome, they are more concentrated
around the transcriptional start sites [35]. To reduce
false predictions we focused on the proximal promoters
which have been proven to successfully predict tissue-
specific regulatory elements [21,36]. It is however
worthy to note that the use of 1 kb promoter sequences
has limitation for the prediction of tissue TF pairs when
compared to the experimental approaches such as ChIP-
chip experiment, in which TF pairs can be detected any-
where in the genome. Considering no benchmark pro-
moter sequence dataset is currently available for
computational prediction of functional TF pairs, the use
of 1 kb promoter sequences and our computational
approach nevertheless provide an alternative way for tis-
sue interacting TF discovery. Promoter sequences within
1 kb upstream of transcriptional starting sites for both
human and corresponding mouse orthologous genes
were extracted from the UCSC genome browser (hg18
March 2006 assembly, mm9 July 2007 assembly). Ortho-
logous genes with promoter sequences from both
human and mouse were selected for further analysis.
This procedure resulted in 208 to 278 orthologous pro-
moter sequences for tissue-expressed genes and 986
orthologous promoter sequences for housekeeping
genes.
Prediction of TF pairs and tissue TF pairs
The procedures for predicting TF pair are basically the
same as previously described [22] (Additional File 1).
Briefly, background sequences were created by shuffling
the DNA sequences within each promoter by either
mixing completely or keeping dinucleotides together.
These background sequences are preferable to using
intergenic sequences which usually are AT-rich or exo-
nic sequences whose nucleotide distributions tend to be
biased, when compared to the test promoter sequences.
The resulting shuffled sequences from human and
mouse, together with the original promoter sequences,
were employed for TFBS detection using the Match®
program [37], for which the profile parameter was set to
“minimize the sum of false positives and negatives”,a n d
the 214 non-redundant vertebrate PWMs from the pro-
fessional TRANSFAC11.4 database [25]. To detect
enriched TF pairs out of 23,005 (214*215/2) possible
combinations of 2 TFs, distance constraints were first
applied for the selection of co-occurring TFBSs with a
defined maximum distance between 2 TFBSs. A total of
10 distances were defined, ranging from the smallest 20
bp to the largest 200 bp with a 20 bp increment. The
assumption behind the distance constraint is that func-
tional TFBS pairs are more distance-restricted than ran-
dom co-occurrence of TFBSs [19,38]. This is true not
only in human, for which we found that functional TF
pairs were enriched within 200 bp distance ranges [22],
but also in Drosophila, in which short-range linkages (<
50 bp) between TFs was overrepresented but mid-range
distances (100-500 bp) between TFs was depleted [39].
Enrichment of TFBS pairs for each distance constraint
was achieved by computing the ratio of counts for a
particular TFBS pair in real promoter sequences vs. the
counts of the same TFBS pair in background sequences.
To reduce noise while keeping as many as TFBS pairs
for the integration of function conservation analysis
described below, TFBS pairs with ratio > 1 in more than
5 distance constraints were selected.
A two-step analysis procedure was employed to com-
pute the enrichment of overlapping orthologous genes
for a particular TFBS pair. First, a cutoff threshold of at
least 10% overlapping orthologous genes between mouse
and human was set up for selecting genes whose pro-
moters contained the TFBS pair. The enrichment of
overlapping orthologous genes was then estimated by
computing the ratio of overlapping orthologous genes
from real promoter sequences against those from
shuffled sequences. This analysis was performed for
each distance constraint. The integration of function
conservation for each TF pair was achieved by estimat-
ing the correlation (Pearson correlation coefficients)
between the 10 enriched TFBS pairs and 10 correspond-
ing enriched overlapping orthologous genes from the
same distance constraint. Permutation tests were
employed to estimate the statistical significance of corre-
lation by randomly matching the 10 TFBS pair ratios
with the 10 overlapping orthologous gene ratios. For
multiple test correction, a cutoff threshold of q-value <
0.05 was applied. TF pairs are those passing the cutoff
and common between human and mouse.
We next filtered TF pairs of housekeeping genes from
those in each tissue (Figure 1a). This was done by
removing TF pairs in a particular tissue common to
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in each tissue were more tissue-specific, and therefore,
were defined as tissue TF pairs. Similar results were
obtained from using background sequences of either
completely mixed nucleotides or keeping dinucleotides
together or completely mixing nucleotides. The results
from completely mixed nucleotides were used.
Clustering analysis
To group tissues based on their tissue TF pairs, a 2549
(tissue TF pairs) × 79 (tissues) matrix with binary num-
bers was first built for all tissue TF pairs in the 79
human tissues. The presence of a tissue TF pair in the
matrix was labeled with 1 and the absence was labeled
with 0. A distance matrix was then built using the “bin-
ary” method, and hierarchical clustering was subse-
quently performed using the “complete” agglomeration
method. All analysis was performed using the R statisti-
cal package [40].
Predicting multiple interacting TFs
A two-step analysis of TFBS conservation and enrich-
ment of overlapping orthologous genes was performed
to predict interactions of 3 TFs. For TFBS conservation,
the identified tissue TFBS pairs were first used to con-
struct all possible 3-TFBS combinations by searching
paired tissue TFBS pairs with one shared TFBS between
each other on exactly the same location of a gene’sp r o -
moter (Figure 1b) in a particular tissue. Orthologous
gene pairs containing conserved 3-TFBS combination
between human and mouse were then selected. Con-
served 3-TFBS combinations are those whose 3 TFBSs
have the same order and orientation on the promoter
sequences between human and mouse orthologous
genes. For enrichment of overlapping orthologous genes
in a tissue, however, multiple interacting TFs from dif-
ferent orthologous gene pairs were considered to be the
same as long as they contained the same 3 TFs.
Enriched multiple interacting TFs are those with 3-
TFBS combinations occurring on at least 10 orthologous
gene promoters and with their target orthologous genes
displaying significant overlap between human and
mouse (p =3×1 0
-2 to < 10
-36 and q < 0.05).
Statistical methods for enrichment analyses
Two main statistical methods were employed for esti-
mating the significance of enrichment in this study. For
validating predicted TF pairs and tissue TF pairs by
known interacting TFs, the binomial distribution prob-
ability, as shown below, was used to determine if known
interacting TFs were present more often in the pre-
dicted TF pairs or tissue TF pairs than in a randomly
selected group from a given list of TFs.
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significance of known liver-specific interacting TFs in
our predicted tissue TF pairs from liver tissue, the n is
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the predicted tissue TF pairs from this study; N the
number of tissue TF pairs from liver tissue; and pf the
background probability of liver-specific TF pairs in all
possible combinations of 2 TFs from 214 PWMs.
The statistical significance was computed using the
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ping functions between muscle tissues, and (2)
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PX c
S
x
NS
Sx
N
S
xc
ss
()
min( , )




















  
11
2
2
12
In the case of overlapping orthologous genes in pre-
dicting multiple interacting TFs, for example, c is the
number of orthologous gene pairs containing conserved
3-TFBS combination between human and mouse; N the
number of tissue-expressed genes for a particular tissue;
S1 and S2 are the numbers of tissue-expressed genes
with 3-TFBS combinations corresponding to those in c
for human and mouse, respectively. The resulting p-
value is the probability of observing c or more ortholo-
gous gene pairs containing conserved 3-TFBS combina-
tion from two sets of size S1 and S2 drawn from a set of
N tissue-expressed genes.
List of abbreviations
TF: transcription factor; TFBS: transcription factor bind-
ing site; PWM: position weight matrices.
Additional file 1: Flowchart of analysis procedure for TF pair
prediction.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-2164-11-
49-S1.pdf]
Additional file 2: Lists tissue and tissue-unique TF pairs and their
potential functions for the 79 human tissues.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-2164-11-
49-S2.XLS]
Additional file 3: Lists tissue-type TF pairs for the 11 selected tissue
groups.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-2164-11-
49-S3.XLS]
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Page 13 of 15Additional file 4: Shows the 84 tissue-type TF-TF interaction
networks from the 11 tissue-type groups.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-2164-11-
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